Clinical Trial Update: Clinical Study of the Safety and Efficacy of ASCT Combined With CD7-CART in the Treatment of CD7+ TCL [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of autologous stem cell transplantation combined with CD7-CART therapy for CD7-positive T-cell lymphom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cd7-positive T-cell Lymphoma
• T-cell Lymphoma

Drugs mentioned

• Autologous stem cell transplantation (ASCT) (autologous stem cell transplantation)
• CD7-CART (CD7 CAR-T cell therapy)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: CD7 Positive, T - Cell Lymphoma | Phase 2 | Status: RECRUITING